Archives

Choose a date range

From To

Choose one or more categories

Categories:



Show only original CenterWatch stories

 


Dicerna Pharmaceuticals moves to Cambridge, Mass., will add 10 jobs

Friday, February 27, 2015 02:30 PM

Dicerna Pharmaceuticals, a developer of RNAi therapeutics, has opened a new 37,000-square-foot office and R&D laboratory in the Alewife area of Cambridge, Mass.

More... »


Biota Pharmaceuticals to acquire Anaconda Pharma

Friday, February 27, 2015 02:29 PM

Biota Pharmaceuticals, based in Alpharetta, Ga., has agreed to acquire Anaconda Pharma, a privately held biotech company based in Paris.

More... »


JSR, CMIC and INCJ of Japan to acquire KBI Biopharma

Friday, February 27, 2015 02:27 PM

JSR, along with Tokyo-based CMIC and Innovation Network Corporation of Japan (INCJ), have agreed to acquire KBI Biopharma, a biopharmaceutical contract development and manufacturing organization with facilities in Durham and Research Triangle Park, N.C. and Boulder, Colo. Following completion of the acquisition, JSR will own the majority interest in KBI within the acquiring group.

More... »

Pearl IRB granted AAHRPP accreditation

Thursday, February 26, 2015 03:32 PM

Pearl IRB, an Indianapolis-based provider of central IRB review services, has received accreditation by the Association for the Accreditation of Human Research Protection Programs (AAHRPP). Pearl IRB earned this distinction in December 2014 by demonstrating extensive safeguards in all levels of the research operations and abiding by high standards of excellence for all research.

More... »

Roche, BioMed X collaborate to develop nanomaterial-based biosensors

Thursday, February 26, 2015 03:30 PM

Roche and BioMed X, a collaboration model at the interface between academia and industry based in Heidelberg, Germany, have entered into a collaboration agreement to establish a research group focusing on the development of a novel sensor technology platform based on new nanomaterials such as graphene.

More... »

Recursion Pharmaceuticals wins $1.5M NIH grant for rare diseases

Thursday, February 26, 2015 03:28 PM

Recursion Pharmaceuticals, an emerging biotech company founded in 2013 based on technology developed at the University of Utah, has been awarded $1.46 million from the NIH via the National Center for Accelerating Translational Sciences (NCATS). Just over half of the award is available in the first year; the rest will come through in year two pending availability of funds and project progress. The award will support the further development of Recursion’s Drug Screening Platform for hundreds of rare genetic diseases.

More... »

Huntingdon Life Sciences, Harlan Laboratories to rebrand

Thursday, February 26, 2015 03:21 PM

Huntingdon Life Sciences (HLS) and Harlan Laboratories will formally merge under one brand to reflect a new integrated management structure and broader product and service offerings of the combined organizations.

More... »

FDA approves new antibacterial drug Avycaz

Thursday, February 26, 2015 01:12 PM

The FDA has approved Avycaz (ceftazidime-avibactam), a new antibacterial drug product, to treat adults with complicated intra-abdominal infections (cIAI), in combination with metronidazole, and complicated urinary tract infections (cUTI), including kidney infections (pyelonephritis), who have limited or no alternative treatment options.  

More... »

Stuart Horowitz appointed to ACRP editorial advisory board

Thursday, February 26, 2015 01:09 PM

WIRB-Copernicus Group (WCG), a provider of regulatory and ethical review services and software to support clinical research, has announced that Stuart Horowitz, Ph.D., M.B.A., its president of institutions and institutional services, has been appointed to the Association of Clinical Research Professionals' (ACRP's) editorial advisory board for a two-year term.

More... »

Quintiles named to Fortune magazine's 2015 list of World’s Most Admired Companies

Thursday, February 26, 2015 01:05 PM

Quintiles, a biopharmaceutical services company, has been named to Fortune magazine’s World’s Most Admired Companies list for 2015.

More... »

CenterWatch Drugs in Clinical Trials
CWWeekly

February 23

Venture capital investors funding novel drug R&D three times more than companies repurposing, improving existing drugs

In appreciation: Karen Woodin will be remembered for her teaching, writing and lasting friendships

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs